SCHEDULE 14A
                                 (Rule 14a-101)
                     INFORMATION REQUIRED IN PROXY STATEMENT
                            SCHEDULE 14A INFORMATION

                    Proxy Statement Pursuant to Section 14(a)
                     of the Securities Exchange Act of 1934

Filed by the Registrant |X|

Filed by a Party other than the Registrant |_|

Check the appropriate box:

|_|   Preliminary Proxy Statement           |_|  Confidential, for Use of the
                                                 Commission Only (as permitted
                                                 by Rule 14a-6(e)(2))
|X|   Definitive Proxy Statement

|_|   Definitive Additional Materials

|_|   Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12

                               CyPost Corporation
                (Name of Registrant as Specified in Its Charter)

    (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

|X|   No fee required.

|_|   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1)   Title of each class of securities to which transaction applies:

(2)   Aggregate number of securities to which transaction applies:

(3)   Per unit price or other underlying value of transaction  computed pursuant
      to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
      calculated and state how it was determined):

(4)   Proposed maximum aggregate value of transaction:

(5)   Total fee paid:

|_|   Fee paid previously with preliminary materials.

|_|   Check box if any part of the fee is offset as  provided  by  Exchange  Act
      Rule  0-11(a)(2)  and identify the filing for which the offsetting fee was
      paid  previously.  Identify the previous filing by registration  statement
      number, or the form or schedule and the date of its filing.

(1)   Amount Previously Paid:

(2)   Form, Schedule or Registration Statement no.:

(3)   Filing Party:

(4)   Date Filed:



                               CYPOST CORPORATION
                       1281 West Georgia Street, Suite 900
                           Vancouver, British Columbia

January 14, 2002

To Our Stockholders:

      You  are  cordially   invited  to  attend  the  2001  Annual   Meeting  of
Stockholders of CyPost  Corporation (the "Company").  The Annual Meeting will be
held at 2:00 p.m.,  local time,  on January 29,  2002,  at the offices of Kaplan
Gottbetter & Levenson, LLP, 630 Third Avenue, New York, NY 10017.

      The Notice of Meeting and Proxy  Statement on the following pages describe
the matters to be presented at the Annual Meeting.

      Included  with the Proxy  Statement  are  copies of the  Company's  Annual
Report on Form 10-KSB,  excluding  exhibits,  for the fiscal year ended December
31, 2000 (the "Form  10-KSB") and  Quarterly  Report on Form  10-QSB,  excluding
exhibits,  for the fiscal quarter ended  September 30, 2001 (the "Form 10-QSB").
We  encourage  you to read  the  Form  10-KSB  and  Form  10-QSB.  They  include
information on the Company's operations, markets, products and services, as well
as the  Company's  December  31, 2001  audited  financial  statements  (see Form
10BKSB) and September 30, 2001 reviewed financial statements (see Form 10-QSB).

      It is important  that your shares be represented at this meeting to assure
the presence of a quorum. Whether or not you plan to attend the meeting, we hope
that you will have your stock  represented  by completing,  signing,  dating and
returning  your  proxy in the  enclosed  envelope  as soon as  possible.  Unless
revoked  by you  prior  to the time it is  voted,  your  stock  will be voted in
accordance  with the  instructions  you have given in your proxy.  Returning the
proxy does not  deprive you of your right to attend the meeting and to vote your
shares in person for the matters acted upon at the meeting.

      We look forward to seeing you at the Annual Meeting.

                                    Sincerely,

                                    /s/ Sandra Lynn Warren
                                    Sandra Lynn Warren
                                    President, Treasurer, Secretary and Director



                               CYPOST CORPORATION
                       1281 West Georgia Street, Suite 900
                       Vancouver, British Columbia V6E3J7

                    NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

      The Annual Meeting of Stockholders (the "Meeting") of CyPost  Corporation,
a Delaware  corporation (the  "Company"),  will be held at the offices of Kaplan
Gottbetter & Levenson,  LLP, 630 Third Avenue, New York, NY 10017 on January 29,
2002, at 2:00 p.m. local time, for the following purposes:

(1)   To elect three (3)  directors  to serve  until the next Annual  Meeting of
      Stockholders  and until their  respective  successors shall have been duly
      elected and qualified;

(2)   To approve an  amendment to the  Company's  Certificate  of  Incorporation
      increasing the number of authorized  shares of the Company's  common stock
      from 30,000,000 to 200,000,000 shares;

(3)   To approve an  amendment to the  Company's  Certificate  of  Incorporation
      granting the  Company's  board of directors  the authority to adopt one or
      more shareholder rights plans, rights agreements or other forms of "poison
      pills" in the future without further shareholder approval.

(4)   To ratify the  appointment of Good Swartz Brown & Berns LLP as independent
      auditors for the year ended December 31, 2001;

(5)   To approve an amendment to the Company's  By-Laws  providing for the board
      of directors to consist of a minimum of three (3) persons and a maximum of
      seven (7) persons; and

(6)   To transact such other business as may properly come before the Meeting.

      Holders  of Common  Stock  $.001 par  value,  of  record,  at the close of
business  on  December  31,  2001 are  entitled  to notice of and to vote at the
Meeting, and at any continuation or adjournment thereof. A complete list of such
stockholders will be open to the examination of any stockholder at the Company's
principal  executive offices at 1281 West Georgia Street,  Suite 900, Vancouver,
British  Columbia V6E3J7 for a period of 10 days prior to the Meeting and on the
day of the Meeting.

      IT IS IMPORTANT THAT YOUR SHARES BE  REPRESENTED  REGARDLESS OF THE NUMBER
OF SHARES YOU MAY HOLD. WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING IN PERSON,
PLEASE  COMPLETE,  DATE AND SIGN THE ENCLOSED PROXY CARD AND MAIL IT PROMPTLY IN
THE ENCLOSED RETURN ENVELOPE.  THE PROMPT RETURN OF PROXIES WILL ENSURE A QUORUM
AND SAVE THE COMPANY THE EXPENSE OF FURTHER SOLICITATION. EACH PROXY GRANTED MAY
BE  REVOKED BY THE  STOCKHOLDER  GRANTING  SUCH  PROXY AT ANY TIME  BEFORE IT IS
VOTED.  IF YOU  RECEIVE  MORE  THAN ONE  PROXY  CARD  BECAUSE  YOUR  SHARES  ARE
REGISTERED  IN  DIFFERENT  NAMES OR  ADDRESSES,  EACH SUCH PROXY CARD  SHOULD BE
SIGNED AND RETURNED TO ENSURE THAT ALL OF YOUR SHARES WILL BE VOTED.

                                    By Order of the Board of Directors

                                    /s/ Sandra Lynn Warren
                                    Sandra Lynn Warren
                                    President, Treasurer, Secretary and Director

Vancouver, British Columbia
January 14, 2002



                               CYPOST CORPORATION
                       1281 West Georgia Street, Suite 900
                       Vancouver, British Columbia V6E3J7

                                 PROXY STATEMENT

      This Proxy Statement is furnished in connection  with the  solicitation by
the Board of Directors of CyPost  Corporation  (the  "Company") of proxies to be
voted at the Annual Meeting of Stockholders of the Company to be held on January
29, 2002 (the  "Meeting") at 2:00 p.m.,  local time, and at any  continuation or
adjournment  thereof.  Holders  of  record  of common  stock,  $0.001  par value
("Common  Stock") as of the close of  business  on December  31,  2001,  will be
entitled  to  notice  of and to vote at the  Meeting  and  any  continuation  or
adjournment  thereof.  As of that date,  there were 23,189,525  shares of Common
Stock issued and  outstanding and entitled to vote.  This Proxy  Statement,  the
accompanying  proxy,  the Company's  Annual Report on Form 10-KSB for the fiscal
year ended December 31, 2000 and the Company's  Quarterly  Report on Form 10-QSB
for the fiscal quarter ended September 30, 2001will be mailed to stockholders on
or about January 14, 2002.

      Each share of Common Stock is entitled to one vote on any matter presented
at the Meeting. Shares of Common Stock may not be voted cumulatively. If proxies
in the  accompanying  form are  properly  executed and  returned,  the shares of
Common Stock represented  thereby will be voted in the manner specified therein.
If not  otherwise  specified,  the  shares of Common  Stock  represented  by the
proxies will be voted (i) FOR the election of the three (3) nominees named below
as  Directors,  (ii) FOR the  approval  of a  proposal  to amend  the  Company's
Certificate  of  Incorporation  to increase the number of  authorized  shares of
common stock to  200,000,000;  (iii) FOR the approval of a proposal to amend the
Company's Certificate of Incorporation granting the Company's board of directors
the authority to adopt one or more shareholder  rights plans,  rights agreements
or other  forms of "poison  pills" in the  future  without  further  shareholder
approval;  (iv) FOR the  ratification  of the appointment of Good Swartz Brown &
Berns LLP as independent  auditors for the year ended December 31, 2001, (v) FOR
the  approval of a proposal to amend the  Company's  By-Laws to require that the
board of directors  consist of a minimum of three (3) and a maximum of seven (7)
directors,  and (vi) in the  discretion of the person named in the enclosed form
of proxy,  on any other  proposals which may properly come before the Meeting or
any  continuation  or adjournment  thereof.  Any Stockholder who has submitted a
proxy may revoke it at any time before it is voted, by written notice  addressed
to and received by the  Secretary of the Company,  by submitting a duly executed
proxy bearing a later date or by electing to vote in person at the Meeting.  The
mere presence at the Meeting of the person executing a proxy does not,  however,
revoke the proxy.

      The expense of printing and mailing  proxy  material  will be borne by the
Company. In addition to the solicitation of proxies by mail, solicitation may be
made by  directors,  officers,  and other  employees  of the Company by personal
interview,  telephone, or facsimile. No additional compensation will be paid for
such solicitation. The Company will request brokers and nominees who hold shares
of Common Stock in their names to furnish proxy material to beneficial owners of
the shares.

      The presence,  in person or by proxy, of holders of shares of Common Stock
having  a  majority  of the  votes  entitled  to be  cast at the  Meeting  shall
constitute a quorum. The affirmative vote by the


                                       1


holders  of a  plurality  of the shares of Common  Stock cast at the  Meeting is
required for the election of  Directors,  provided a quorum is present in person
or by proxy.  The affirmative vote of the holders of a majority of the Company's
outstanding  shares of Common Stock is required for the approval of the proposed
amendments to the Company's  Certificate of Incorporation.  Provided a quorum is
present in person or by proxy,  all other actions  proposed  herein may be taken
upon the affirmative  vote of  Stockholders  possessing a majority of the shares
present or  represented  and  entitled to vote at the Meeting.  Abstentions  and
broker  non-votes are included in the shares present at the Meeting for purposes
of determining  whether a quorum is present.  Abstentions  are counted as a vote
against for  purposes of  determining  whether a proposal  is  approved.  Broker
non-votes  are not  counted  as shares  present  and  entitled  to be voted with
respect to the matter on which the broker has expressly not voted.  Thus, broker
non-votes  will not affect the outcome of any of the matters being voted upon at
the meeting,  expect for the proposed amendments to the Company's Certificate of
Incorporation.  Generally,  broker  non-votes occur when shares held by a broker
for a  beneficial  owner are not voted  with  respect to a  particular  proposal
because (i) the broker has not received voting  instructions from the beneficial
owner, and (ii) the broker lacks discretionary voting power to vote such shares.

      This Proxy  Statement,  together  with the related  Proxy Card,  Notice of
Annual Meeting, the Company's Annual Report on Form 10-KSB,  excluding exhibits,
for the  fiscal  year ended  December  31,  2000  (including  audited  financial
statements  for the  fiscal  year ended  December  31,  2000) and the  Company's
Quarterly  Report on Form 10-QSB,  excluding  exhibits,  for the fiscal  quarter
ended  September  30, 2001  (including  reviewed  financial  statements  for the
quarter ended September 30, 2001) are being mailed to all Stockholders of record
as of the close of business on December 31,  2001.  All of these  materials  are
referred to as the "Proxy  Materials".  In  addition,  the Company has  provided
brokers,  dealers,  banks, voting trustees and their nominees,  at the Company's
expense,  with  additional  copies of the Proxy  Materials  so that such  record
holders could mail such  materials to beneficial  owners on or about January 14,
2002.

                                  PROPOSAL NO.1
                              ELECTION OF DIRECTORS

      At the Meeting,  three (3) directors are to be elected (which number shall
constitute  the entire  Board of  Directors of the Company) to hold office until
the next Annual Meeting of Stockholders  and until their  successors  shall have
been duly elected and qualified, or until their earlier resignation or removal.

      It is the  intention of the persons named in the enclosed form of proxy to
vote the stock represented thereby, unless otherwise specified in the proxy, for
the  election as  Directors of the persons  whose names and  biographies  appear
below.  Two of the three  nominees,  James T. Johnson and Sandra Lynn Warren are
incumbent  directors.  Javan Khazali is also being nominated for election to the
board. In the event any of the nominees  should become  unavailable or unable to
serve as a  Director,  it is intended  that votes will be cast for a  substitute
nominee  designated  by the Board of  Directors.  The Board of Directors  has no
reason to believe  that the  nominees  named will be unable to serve if elected.
Each nominee has  consented to being named in this Proxy  Statement and to serve
if elected.


                                       2


Required Vote

      Directors are elected by a plurality of votes cast.  Abstentions  withheld
and broker non-votes are not counted towards a nominee's total.

                THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR
                THE ELECTION OF EACH OF THE NOMINATED DIRECTORS.

The principal  occupations and business  experience,  for at least the past five
years, of each nominated Director is as follows:

James T. Johnston

      Mr.  Johnston,  60, joined our Board of Directors on January 17, 2000. Mr.
Johnston is, and has been, a licensed pilot for Canadian Airlines,  now known as
Air Canada,  for 35 years and an airline captain for 29 years.  Mr. Johnston has
been active in representing  the airline pilot's union in a number of capacities
and has been involved in several high-level contract negotiations.

Sandra Lynn Warren

      Mrs.  Warren,  35, has been with the Company for more than three years and
joined our Board of  Directors on October 12,  2001.  On October 30, 2001,  Mrs.
Warren  was  appointed  as our  president,  treasurer  and  principal  financial
officer.  She has a diverse background in office and administrative  management.
Mrs.  Warren  has  worked in  administration  and  accounting  in a  variety  of
industries including print media, hospitality and group insurance. Mrs. Warren's
responsibilities  include handling internal accounting  matters,  overseeing our
SEC filings, interacting with our legal counsel and independent accountants, and
serving as our contact person for dealings involving the listing and sale of our
stock.

Javan Khazali

      Mr.  Khazali,  38, joined the Company in July of 2001 as Vice President of
Administration. With extensive experience in the services sector, Mr. Khazali is
responsible for the  development  and continuing  management of our business and
training  programs,  including  human  resources.  Prior to joining  us, he held
various  management  positions  including (i) Operation  Manager for 10 high-end
chain  restaurants in the U.S. and Canada,  (ii) Director of Operations for nine
restaurants where he was responsible for supervision of 300 plus employees,  and
(iii) most recently as Managing  Partner of two local  restaurants  where he was
responsible  for  supervision  of  45  employees.   Mr.  Khazali  is  an  active
philanthropist,   supporting  local  community   initiatives   including  Family
Services,  and Face the World  Foundation,  and resides in the Greater Vancouver
area.


                                       3


Compensation of Directors

      Except as set forth  herein,  during the fiscal  year ended  December  31,
2000,  members of the Company's  Board received no  compensation  for serving as
Board members.  On August 1, 2000,  directors Carl Whitehead,  Robert Sendoh and
Tom  Johnston  each  received  75,000  restricted  shares of our common stock in
consideration of their services as directors.

Committees and Meetings of the Board

      The Company's Board of Directors has the authority to designate from among
its members an executive committee and one or more other committees.  During the
fiscal year ended December 31, 2000 ("Fiscal 2000"),  no such committees were in
existence.  During  Fiscal  2000,  there were nine (9)  meetings of the Board of
Directors.  Each  meeting was attended by all  directors  serving as such at the
time of the respective meetings.  The Board of Directors also acted by unanimous
written consent on numerous other occasions.

                        EXECUTIVE OFFICERS AND DIRECTORS

      The following table identifies the current executive  officers,  directors
and director nominees of the Company:

        Name                   Age     Capacities in Which Served
        ----                   ---     --------------------------

        James T. Johnson       60      Chairman

        Robert Sendoh          51      Director

        Sandra Lynn Warren     35      President, Treasurer, Secretary, Chief
                                       Financial Officer and Director

        Javan Khazali          38      Vice President - Administration

      None of the Company's executive officers is related to any other executive
officer or to any Director of the Company. Executive officers of the Company are
elected by the Board of  Directors  and serve  until their  successors  are duly
elected and qualified.

                             EXECUTIVE COMPENSATION

Summary Compensation Table

      The  following  table  provides  certain  summary  information  concerning
compensation  paid by the Company during each of the fiscal years ended December
31, 2000, December 31, 1999 and December 31, 1998, to all persons that served as
the Company's chief executive officer at any time


                                       4


during the fiscal year ended December 31, 2000. No executive  officers  received
compensation  in excess of $100,000  during the fiscal year ended  December  31,
2000.



                                      Annual Compensation                            Long-Term Compensation
                        ---------------------------------------------  -----------------------------------------------

                        Fiscal Year                                                                           All
  Name and Principal       Ended                            Other      Options/    Restricted   LTIP         Other
       Position         December 31    Salary    Bonus   Compensation    SARs     Stock Awards  Payouts   Compensation
       --------         -----------    ------    -----   ------------    ----     ------------  -------   ------------
                                                                                      
Robert Sendoh, Chief        2000       $44,115     0          0            0        75,000 (3)     0          0
Executive Officer,          1999        82,795     0          0            0             0         0          0
Chairman (1)                1998             0     0          0            0             0         0          0

Steven M. Berry,            2000        $5,207     0          0            0             0         0          0
Chief Executive             1999       120,000     0          0            0       600,000 (4)     0          0
Officer, President (2)      1998             0     0          0            0             0         0          0


(1)   Mr.  Sendoh  served as our chief  executive  officer from January 17, 2000
      through August 31, 2000.

(2)   Mr. Berry served as our chief executive officer from January 4, 1999 until
      January 17, 2000.

(3)   Represents shares received for serving as a director during 2000.

(4)   These shares are one of the subjects of a litigation between Mr. Berry and
      us. See Certain Relationships and Related Transactions.

Stock Options

      There  were no grants of stock  options  to either of the named  executive
officers in fiscal year 2000 or at any other time.

Employment Agreements

      Mr.  Berry has not been  employed  by the  Company in any  capacity  since
January 17, 2000. Mr. Sendoh currently serves as one of our directors but is not
an employee of the Company.

         SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

      The Company's  Common Stock is the only class of stock entitled to vote at
the  Meeting.  Only  stockholders  of record as of the  closing of  business  on
December 31, 2001 (the "Record  Date") are entitled to receive  notice of and to
vote at the 2001 Annual Meeting of  Stockholders.  As of the Record Date,  there
were  approximately 101 holders of record of the Company's Common Stock, and the
Company had outstanding  23,189,525 shares of its Common Stock. Each outstanding
share is entitled to one (1) vote at the Meeting. The following table sets forth
certain  information,  as of the Record  Date,  with  respect to holdings of the
Company's  Common  Stock  by (i) each  person  known  by the  Company  to be the
beneficial  owner of more than 5% of the total  number of shares of Common Stock
outstanding  as of such  date,  (ii)  each  of the  Company's  directors  (which
includes all  nominees),  and  executive  officers,  and (iii) all directors and
executive  officers  as a  group.  Except  as  otherwise  indicated,  the  named
beneficial owner owns all shares indicated directly.


                                       5


                                              Amount and Nature of   Percentage
Name and Address of Beneficial Owner          Beneficial Ownership    of Class
------------------------------------          --------------------    --------
Robert Sendoh ................................       355,000            1.53%
1281 West Georgia Street
Suite 900
Vancouver, BC V6E 3J7

James T. Johnston ............................       206,000(1)          .89%
1281 West Georgia Street
Suite 900
Vancouver, BC V6E 3J7

Sandra Lynn Warren ...........................        20,000             .08%
1281 West Georgia Street
Suite 900
Vancouver, BC V6E 3J7

Javan Khazali ................................        41,000             .17%
1281 West Georgia Street
Suite 900
Vancouver, BC V6E 3J7

Kelly Shane Montalban ........................     2,116,957(2)         9.13%
P.O. Box 700
Lions Bay, BC V0N 2E0

All executive officers and directors                 622,000            2.68%
  as a group (4 persons)......................

----------
(1)   Includes  25,000 shares owned by Mr.  Johnston's  wife and an aggregate of
      75,000 shares owned in trust for Mr. Johnston's three daughters.

(2)   Includes 7,500 shares owned by Mr. Montalban's wife and 7,500 shares owned
      in trust for Mr. Montalban's daughter.

Compliance with Section 16(a) of the Exchange Act

      Section 16(a) of the Securities Exchange Act of 1934, as amended, requires
our directors and executive officers, and persons who beneficially own more than
10% of our common stock, to file reports of beneficial  ownership and changes in
beneficial  ownership  of our  securities  with  the  SEC on  Forms  3  (Initial
Statement  of  Beneficial  Ownership),  4  (Statement  of Changes of  Beneficial


                                       6


Ownership  of  Securities  and 5 (Annual  Statement of  Beneficial  Ownership of
Securities).  Directors,  executive  officers and beneficial owners of more than
10% of our  common  stock are  required  by SEC  regulations  to furnish us with
copies of all Section 16(a) forms that they file.  Except as otherwise set forth
herein,  based solely on our review of the copies of such forms furnished to us,
or written  representations  that no reports were required,  we believe that for
the period from  January 1, 2000  through  December  31,  2000,  all  directors,
executive  officers and greater than 10%  beneficial  owners  complied  with all
Section 16(a) filing requirements applicable to them. However, Robert Sendoh was
late in filing  one Form 4;  Robert  Adams  was late in filing  one Form 3; Carl
Whitehead  was late in filing one Form 4, James T.  Johnston  was late in filing
one Form 3 and one Form 4; Tami  Allan was late in filing  one Form 3; and Kelly
Shane  Montalban  was late in filing  seven Forms 4. We do not believe that Blue
Heron Venture Fund Ltd, a 10%  beneficial  owner during  Fiscal 2000,  filed any
Forms 3 or Forms 4.

                         INDEPENDENT PUBLIC ACCOUNTANTS

      Arthur  Andersen  LLP   ("Andersen")   were  our  independent   certifying
accountants  for the fiscal year ended December 31, 1999. On October 24, 2000 we
terminated that firm's appointment and subsequently  engaged Hollander,  Lumer &
Co.,  LLP  ("HL") as our  certifying  accountants  for the  fiscal  year  ending
December 31, 2000. As the result of a March 28, 2001 merger, the accounting firm
of Good Swartz Brown & Berns LLP  ("GSBB")  succeeded to the business of HL. The
termination  of  Andersen  and  appointment  of HL was  approved by our board of
directors.  Prior to their  appointment,  we did not  consult  with  GSBB,  with
respect to any accounting or other matters.

      The report of Andersen  on our  financial  statements  for the fiscal year
ended December 31, 1999  contained no adverse  opinion or disclaimer of opinion,
nor was it qualified or modified as to  uncertainty,  audit scope or  accounting
principle  except that the report was  modified  with  respect to our ability to
continue as a going concern.

      In connection with their audit for the fiscal year ended December 31, 1999
and during the subsequent  interim period preceding their dismissal,  there were
no disagreements  between us and Andersen on any matter of accounting principles
or practices,  financial statement disclosure,  or auditing scope or procedures,
which  disagreements,  if not resolved to their satisfaction,  would have caused
Andersen  to  make  reference  to the  subject  matter  of the  disagreement  in
connection with their report.

      In connection with their audit for the fiscal year ended December 31, 1999
and during the subsequent interim period preceding their dismissal, Andersen did
not advise us that:

      o     internal  controls  necessary for us to develop  reliable  financial
            statements did not exist;

      o     information  had come to their  attention that led them to no longer
            be able to rely on our  management's  representations  or made  them
            unwilling to be associated with the financial statements prepared by
            our management;


                                       7


      o     there was a need to expand  significantly  the scope of their audit,
            or that  information  had come to their  attention  during such time
            periods that if further  investigated  might: (i) materially  impact
            the  fairness or  reliability  of either a  previously  issued audit
            report  or the  underlying  financial  statement;  or the  financial
            statements  issued  or to be  issued  covering  the  fiscal  periods
            subsequent  to the  date of the  most  recent  financial  statements
            covered by an audit report, or (ii) cause it to be unwilling to rely
            on  our  management's  representations  or be  associated  with  our
            financial statements;

      o     information  had come to their  attention  that  they had  concluded
            materially  impacted the fairness or reliability of either (i) their
            audit report or the  underlying  financial  statements,  or (ii) the
            financial  statements  issued or to be issued  covering  the  fiscal
            periods  subsequent to the date of the financial  statements covered
            by their audit report.

      A representatives of GSBB is expected to be present at the annual meeting.

Audit Fees

      The aggregate fees charged to us for  professional  services  rendered for
the audit of our  financial  statements  for the fiscal year ended  December 31,
2000 and the review of our financial  statements  for the fiscal  quarters ended
March  31,  2001,  June 30,  2001 and  September  30,  2001  were  approximately
$150,000.

Financial Information System Design and Implementation Fees

      No fees were  charged  to us by our  principal  accountant  for  financial
information  system  design and  implementation  with respect to the fiscal year
ended December 31, 2000.

All Other Fees

      No fees were charged to us by our principal accountant with respect to the
fiscal year ended December 31, 2000 other than those disclosed  herein under the
caption "Audit Fees."

                 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

      During the period February 9, 1999 through June 18, 2001, we obtained most
of our financing through Blue Heron Venture Fund Ltd., ("Blue Heron"). The loans
were made under  agreements  pursuant to which we could borrow up to $16,000,000
in unsecured loans from Blue Heron.  Effective June 18, 2001 Blue Heron withdrew
this credit  facility.  All of the loans were  evidenced by  convertible  demand
notes (the "Blue Heron Demand Notes") which bore interest at 8% per annum,  were
payable on demand and were  convertible  into shares of our common stock at Blue
Heron's option.  On June 18, 2001, all outstanding  Blue Heron Demand Notes were
cancelled  and   subsequently   replaced  by  notes  that  were  issued  to  the
shareholders  of Blue Heron and its fund manager.  These notes were cancelled on
September 20, 2001, in connection with our settlement of


                                       8


a lawsuit against a principal shareholder for violations of Section 16(b) of the
Securities  Exchange Act of 1934, as amended,  as more fully described below. On
August 16,  1999,  $1,000,000  aggregate  principal  amount of Blue Heron Demand
Notes were  converted  into  1,500,000  shares of common stock,  at a conversion
price of $0.67  per  share.  On  November  24,  1999,  an  aggregate  additional
principal amount of $3,000,000 of Blue Heron Demand Notes were converted into an
additional  3,000,000  shares of common stock, at conversion  price of $1.00 per
share. During the fiscal year ended December 31, 2000, we borrowed an additional
$1,210,000  from Blue Heron,  resulting  in an aggregate  outstanding  principal
amount of the loans of $2,085,000 as at December 31, 2000. We did not borrow any
additional funds from Blue Heron subsequent to December 31, 2000.

      During the fiscal year ended  December 31, 2000,  we borrowed an aggregate
of  $125,000  from  Pacific  Gate  Capital   Corporation   ("Pacific  Gate"),  a
corporation  owned by Kelly Shane  Montalban,  a principal  shareholder of ours.
$25,000 of this amount was  outstanding  on September  20, 2001,  at which time,
pursuant to the  settlement of a lawsuit by us against Mr.  Montalban,  the loan
was paid in full.

      On March 31,  2000,  we  commenced  suit in the  Supreme  Court of British
Columbia,  Action  #S001822,  Vancouver  Registry  against  Tia Berry  (the "Tia
Action"),  the wife of Steven Berry  ("Berry"),  our former  president and chief
financial  officer.  In the Tia Action, we claim $42,516 (CDN) from Tia Berry on
account of monies paid to her by us which she was not  entitled to receive.  Tia
Berry has filed a  Statement  of Defense in the Tia Action in which she  alleges
that the payments  which she received from us were to reimburse her for business
expenses  which she had charged to her credit cards on behalf of Berry.  The Tia
Action has not yet been set for  trial.  On April 4, 2000,  Berry  Commenced  an
action in the Supreme Court of the State of New York,  County of New York (Index
No.  601448/2000),  against us and  Continental  Stock  Transfer & Trust Company
("Continental"),  (the "New York Action"). In the New York Action, Berry claimed
damages  for  alleged  conversion,  fraud,  breach  of  contract  and  breach of
fiduciary  duty all arising from the alleged  wrongful Stop Transfer Order which
the Company  placed  relating to 75,000  shares of the  Company's  common  stock
registered in Berry's name and our cancellation of a further 600,000 shares (the
"Contingent  Shares").  The complaint in the New York Action  claims  damages in
excess of $3,000,000  with the precise  amount to be determined at trial.  Berry
received the 600,000  Contingent  Shares upon  condition that he would remain in
our employ as chief  executive  officer for at least two years.  Berry commenced
his employment  with us on January 4, 1999, and resigned his employment  with us
on January 17, 2000. Following Berry's resignation,  we attempted to have a Stop
Transfer  Order issued with respect to the 75,000  shares  registered in Berry's
name and cancel the 600,000  Contingent  Shares. The Stop Transfer Order was not
effective and Berry subsequently sold the 75,000 shares.

      On May 19, 2000 CyPost and ePost  Innovations,  Inc., a subsidiary of ours
commenced  suit in the  Supreme  Court of  British  Columbia,  Action  #S002798,
Vancouver Registry,  against Berry and his wife, Tia Berry (the "BC Action"). In
the BC Action,  we are  seeking an order  directing  Berry to return the 600,000
Contingent Shares to us for cancellation for an order entitling us to cancel the
same on the basis that Berry did not fulfill  the  employment  conditions  which
were  the  condition  precedent  to his  becoming  the  beneficial  owner of the
Contingent  Shares.  In the BC Action, we are also claiming at least Cdn$800,000
from  Berry on  account  of  breach of  fiduciary  duty,  negligence,


                                       9


breach of statutory  duties and breach of contract  arising from Berry's failure
to properly carry out his employment responsibilities.  In the BC Action, we are
also  claiming  Cdn$34,013  from Berry and Tia Berry on account of conspiracy to
defraud and injure us and ePost Innovations by causing certain personal expenses
to be paid by us  rather  than by Berry and Tia  Berry  personally.  We are also
claiming  punitive  and  exemplary  damages  from  Berry and Tia Berry in the BC
Action.

      On May 25, 2000,  we moved in the New York Action for an order  dismissing
the action against us for lack of jurisdiction,  or in the  alternative,  on the
basis of forum non conveniens. On September 5, 2000, the court dismissed the New
York  Action on forum non  conveniens  grounds,  subject to our  making  certain
stipulations in the New York Action.  Those  stipulations have been made and the
appeal  period in the New York  Action has  expired  without  Berry or any other
party  appealing the September 5, 2000 order.  The issues raised by Berry and us
in the New York  Action will be  litigated  in the BC Action  together  with the
further issues raised by us in the BC Action. We feel that Berry's claims in the
New York Action were without  merit and that we will be  successful in obtaining
an order  declaring  that Berry's  600,000  Contingent  Shares be cancelled  and
further entitling us to substantial damages,  although no assurance can be given
that this will be the case.  We intend to  vigorously  purse our position in all
respects.

      On December 21, 2000,  Berry and Tia Berry  commenced  suit in the Supreme
Court of British Columbia, Action #S006790 Vancouver Registry, against us, ePost
Innovations,  Kelly Shane Montalban,  J. Thomas W. Johnston,  Carl Whitehead and
Robert  Sendoh (the "Berry  Action").  Statements  of Defense have been filed on
behalf of us and the other defendants. The Plaintiffs in the Berry Action allege
that the Tia  Action,  the BC Action,  and the action by Kelly  Shane  Montalban
(Supreme  Court of  British  Columbia,  Action  #S002147,  Vancouver  Registry),
against Berry for specific  performance of an option  agreement (the  "Montalban
Action"),  collectively,  amount to an abuse of process,  malicious prosecution,
unlawful  interference  with the  Plaintiff's  economic rights or were commenced
pursuant to a civil  conspiracy to injure the  Plaintiffs.  In the Berry Action,
the  Plaintiffs  seek a  declaration  that  Berry  is  entitled  to the  600,000
Contingent  Shares  and  claim  unspecified   damages  which  are  estimated  at
Cdn$2,000,000  based on the  Statement  of Claim.  They also claim  punitive  or
aggravated  damages  and costs.  We believe  that the  allegations  in the Berry
Action are without merit. We intend to defend them vigorously.

      It is  expected  that the Tia Action,  the BC Action and the Berry  Action
will be  consolidated  for the  purposes of trial due to the fact that there are
numerous  issues of fact and law which are  common to all of these  actions.  We
believe  that trial will likely take place in the fall of 2002.  A loss by us of
the claim against us for monetary  damages would have a material  adverse effect
on our future results of operations, financial condition and liquidity; however,
we do not expect to lose this action and believe, additionally,  that we will be
able to negotiate reasonable payment terms should we lose this suit.

      On January 10, 2001, we issued an option to purchase  1,000,000  shares of
our  common  stock to Robert  Adams,  who,  at such  time,  was  serving  as our
president and chief operating officer, secretary and treasurer. On that date, we
also issued an option to  purchase  125,000  shares of our common  stock to Tami
Allan,  who, at such time,  was serving as our vice  president of North American
operations. The exercise price of each option was $.10 per share and vested over
time.


                                       10


The options were issued pursuant to the exemption from registration contained in
Section 4(2) of the Securities Act of 1933, as amended (the  "Securities  Act"),
for transactions by an issuer not involving a public offering. Mr. Adams and Ms.
Allan are no longer employees of the Company. Their options have been terminated
for cause.

      On June 15,  2001 we filed a Summons  and  Complaint  against  Kelly Shane
Montalban in the United States  District Court for the Southern  District of New
York (CyPost Corp. v. Kelly Shane Montalban,  Civ. 5447). The Complaint  alleged
that,  between  September  1999 and June 15, 2001 (the "Recovery  Period"),  Mr.
Montalban,  and persons whose ownership of our common stock was  attributable to
Mr.  Montalban,  made  numerous  purchases  and  sales  of our  common  stock in
violation of the short swing profit recovery  provisions of Section 16(b) of the
Securities  Exchange Act of 1934, as amended.  ("Section 16(b)").  Section 16(b)
imposes strict liability on corporate insiders, including principal stockholders
such as Mr.  Montalban,  for engaging in short swing trading  activities (a sale
and purchase or purchase  and sale  occurring  within any six (6) month  period)
without  regard to whether true  profits were  realized by the insider from such
trading  activities.  During the Recovery  Period,  Mr.  Montalban made numerous
purchases and sales of our common stock in violation of Section 16(b).  Although
we were not of the belief  that Mr.  Montalban  made any of such  purchases  and
sales based on his  possession of non-public  information,  we were  nonetheless
required by the strict  liability  provisions  of Section 16(b) to seek recovery
from Mr.  Montalban.  We  ultimately  determined  that the amount of short swing
profits  realized by Mr.  Montalban and those persons whose  purchases and sales
within the Recovery Period were  attributable to Mr. Montalban was $2,498,449.46
(the "Recovery Amount").  Mr. Montalban  cooperated fully with our investigation
and subsequently agreed to make payment in full on the Recovery Amount. Pursuant
thereto,  on September 20, 2001 we entered into a Settlement  Agreement with Mr.
Montalban  pursuant to which he paid part of the Recovery  Amount by delivery to
us for cancellation,  on September 20, 2001, various promissory notes of ours on
which we owed an  aggregate of  $2,344,788.24  in principal  and  $44,450.27  in
interest  or a total of  $2,389,238.51.  The notes  delivered  for  cancellation
included  a note  which had been  assigned  to Mr.  Montalban  by the  holder to
satisfy an  obligation  of the  holder to Mr.  Montalban,  notes  which had been
purchased by Mr. Montalban from various individuals known by Mr. Montalban,  and
a note held by Pacific  Gate Capital  Corporation,  a  corporation  owned by Mr.
Montalban.  The balance of the Recovery Amount was paid by Mr. Montalban through
his issuance to us of a five (5) year, 5% promissory  note,  dated September 20,
2001,  in  the  principal  amount  of  $109,210.95.   In  consideration  of  Mr.
Montalban's  execution of the  Settlement  Agreement and payment of the Recovery
Amount,  on October 9, 2001 we  voluntarily  dismissed  our action  against  Mr.
Montalban.

                                 PROPOSAL NO. 2
                           AMENDMENT TO THE COMPANY's
                          CERTIFICATE OF INCORPORATION
                     TO INCREASE NUMBER OF AUTHORIZED SHARES

      On November 23, 2001,  the Board  authorized an amendment to the Company's
Certificate  of  Incorporation  to increase the number of  authorized  shares of
Common Stock,  par value $.001 per share ("Common  Stock" ), from  30,000,000 to
200,000,000. The stockholders are being asked to


                                       11


approve this proposed amendment.  As of December 31,  2001,23,189,525  shares of
Common Stock were issued and outstanding.

Required Vote

      The  approval  of  the  adoption  of  this   amendment  to  the  Company's
Certificate of  Incorporation  requires the affirmative vote of the holders of a
majority of the outstanding  shares of the Company's  Common Stock.  Abstentions
and broker non-votes are not affirmative  votes and therefore will have the same
effect as a vote against the proposal.

            THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR
            APPROVAL OF THE AMENDMENT TO THE COMPANY'S
            CERTIFICATE OF INCORPORATION PROVIDED IN PROPOSAL NO. 2.

      The Board believes that the proposed increase is desirable so that, as the
need may arise, the Company will have more flexibility to issue shares of Common
Stock  without  the  expense  and delay of a special  stockholders=  meeting  in
connection  with  possible  future  stock  dividends  or  stock  splits,  equity
financings,  future opportunities for expanding the business through investments
or acquisitions,  management  incentive and employee benefit plans and for other
general corporate purposes.

      Authorized but unissued shares of the Company's Common Stock may be issued
at such times,  for such  purposes  and for such  consideration  as the Board of
Directors may determine to be  appropriate  without  further  authority from the
Company's stockholders, except as otherwise required by applicable law.

      The increase in authorized Common Stock will not have any immediate effect
on the  rights  of  existing  stockholders.  However,  the  Board  will have the
authority to issue authorized Common Stock without requiring future  stockholder
approval of such issuances,  except as may be required by applicable law. To the
extent that  additional  authorized  shares are issued in the future,  they will
decrease the existing  stockholders=  percentage equity ownership and, depending
upon the price at which  they are  issued,  could be  dilutive  to the  existing
stockholders. The holders of Common Stock have no preemptive rights.

      The  increase in the  authorized  number of shares of Common Stock and the
subsequent  issuance  of such  shares  could  have the  effect  of  delaying  or
preventing  a change in control of the  Company  without  further  action by the
stockholders.  Shares of  authorized  and unissued  Common Stock could be issued
(within the limits imposed by applicable law) in one or more transactions  which
would make a change in control of the Company more difficult, and therefore less
likely.  Any such issuance of additional stock could have the effect of diluting
the earnings per share and book value per share of outstanding  shares of common
Stock, and such additional shares could be used to dilute the stock ownership or
voting rights of a person seeking to obtain control of the Company.


                                       12


                                 PROPOSAL NO. 3
                    AMENDMENT TO THE COMPANY's CERTIFICATE OF
                   INCORPORATION GRANTING BOARD OF DIRECTORS
                RIGHT TO ADOPT SHAREHOLDER RIGHTS PLANS, RIGHTS
                  AGREEMENTS OR OTHER FORMS OF "POISON PILLS"

      On November 29, 2001 the Board  authorized  an amendment to the  Company's
Certificate  of  Incorporation  to grant the Board the authority to adopt one or
more  shareholder  rights  plans,  rights  agreements  or other forms of "poison
pills" in the future without further shareholder approval.  The Stockholders are
being asked to approve this  proposed  amendment.  This  Proposal 3 may have the
effect of discouraging or thwarting unwanted takeovers of the Company.

Required Vote

      The  approval  of  the  adoption  of  this   amendment  to  the  Company's
Certificate of  Incorporation  requires the affirmative vote of the holders of a
majority of the outstanding  shares of the Company's  Common Stock.  Abstentions
and broker non-votes are not affirmative  votes and therefore will have the same
effect as a vote against the proposal.

            THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR
            APPROVAL OF THE AMENDMENT TO THE COMPANY'S
            CERTIFICATE OF INCORPORATION PROVIDED IN PROPOSAL NO. 3.

      The  purpose of a  shareholder  rights plan or rights  agreement  commonly
referred  to as a  "poison  pill" is to  protect  shareholders  against  certain
abusive takeover practices.  It is intended to allow the Board adequate time and
flexibility to negotiate on behalf of the  stockholders  and enhance the Board's
ability to negotiate the highest possible bid from a potential acquiror, develop
alternatives  which may better maximize  stockholder  values,  preserve the long
term value of the Company for the stockholders, and ensure that all stockholders
are  treated  fairly and  equally.  A poison  pill is not  intended to prevent a
takeover on terms that are fair and  equitable  to all  stockholders,  nor is it
designed  as a  deterrent  to a  stockholder's  initiation  of a proxy  contest.
Further,  it does not change the fiduciary standards to be followed by the Board
in responding to a takeover bid.

      The Board may,  pursuant to the terms of a poison pill,  redeem the poison
pill security to permit an acquisition  that it  determines,  in the exercise of
its fiduciary duties,  adequately reflects the value of the Company and to be in
the best  interests  of all  stockholders.  Moreover,  numerous  companies  with
existing  poison pill plans have received  unsolicited  offers and have redeemed
their rights after their  directors were satisfied that the offer, as negotiated
by the target company's board of directors,  adequately reflected the underlying
value of the  company  and was fair and  equitable  to all  stockholders.  Thus,
experience  indicates that poison pill plans do not prevent companies from being
acquired at prices that are fair and adequate to stockholders. Opponents of such
rights  plans or rights  agreements  argue  that  they  injure  shareholders  by
reducing management  accountability and adversely  affecting  shareholder value.
Such  opponents  contend  that  poison  pills are  adopted to  entrench  current
management in office.


                                       13


                                 PROPOSAL NO. 4
               RATIFICATION OF APPOINTMENT OF INDEPENDENT AUDITORS

      The  Board  of  Directors  of the  Company  has,  subject  to  stockholder
approval,  retained Good Swartz Brown & Berns LLP as independent auditors of the
Company for the fiscal year ended  December  31,  2001.  The Board of  Directors
expects that a  representative  of Good Swartz Brown & Berns LLP will be present
at the Annual  Meeting,  will be given an opportunity to make a statement at the
meeting if he desires to do so and will be available  to respond to  appropriate
questions.

Required Vote

      The  ratification  of the  selection  of Good  Swartz  Brown  & Berns  LLP
requires  the  affirmative  vote of the  holders of a majority  of the shares of
Common  Stock  present  or  represented  and  entitled  to vote at the  Meeting.
Abstentions  and broker  non-votes  will be counted as present  for  proposes of
determining whether a quorum is present. Broker non-votes will not be treated as
entitled to vote on this matter at the meeting.  Abstentions are not affirmative
votes and therefore will have the same effect as a vote against the proposal.

            THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE RATIFICATION OF THE
            APPOINTMENT  OF GOOD  SWARTZ  BROWN & BERNS  LLP AS THE  INDEPENDENT
            AUDITORS OF THE COMPANY FOR THE FISCAL YEAR ENDED DECEMBER 31, 2001.

                                 PROPOSAL NO. 5
                              AMENDMENT OF BY-LAWS

      The Board of Directors has proposed that the Company's  By-Laws be amended
to require  the Board to consist of a minimum of three (3) persons and a maximum
of seven (7) persons.  The By-Laws  presently provide that the size of the Board
can be  determined  by a  vote  of a  majority  of the  entire  Board  or by the
Shareholders  of the  Company.  The existing  provision  makes no reference to a
minimum  or maximum  size for the board.  The  purpose of the  amendment  to the
Company's  By-Laws  is to ensure  that the Board  always  consist of a number of
Directors that can direct the Company with maximum efficiency.

Required Vote

      The approval of the adoption of the  amendment  to the  Company's  By-Laws
requires  the  affirmative  vote of the  holders of a majority  of the shares of
Common  Stock  present  or  represented  and  entitled  to vote at the  meeting.
Abstentions  and broker  non-votes  will be counted as present  for  purposes of
determining whether a quorum is present. Broker non-votes will not be treated as


                                       14


entitled to vote on this matter at the meeting.  Abstentions are not affirmative
votes and therefore will have the same effect as a vote against the proposal.

            THE BOARD OF DIRECTORS HAS UNANIMOUSLY APPROVED THE AMENDMENT TO THE
            COMPANY's BY-LAWS AND RECOMMENDS THAT SHAREHOLDERS VOTE FOR PROPOSAL
            NO. 5.

                              STOCKHOLDER PROPOSALS

      Stockholders  who wish to submit  proposals for inclusion in the Company's
proxy  statement  and  form of proxy  relating  to the 2002  Annual  Meeting  of
Stockholders  must  advise the  Secretary  of the Company of such  proposals  in
writing by March 15, 2002.

                                  OTHER MATTERS

      The Board of  Directors  is not aware of any  matter to be  presented  for
action at the  Meeting  other than the  matters  referred  to above and does not
intend to bring any other matters before the Meeting.  However, if other matters
should come before the Meeting,  it is intended that holders of the proxies will
vote thereon in their discretion.

                                     GENERAL

      The  accompanying  proxy is  solicited  by and on  behalf  of the Board of
Directors  of the  Company,  whose  notice of meeting is  attached to this Proxy
Statement.  In addition to the use of the mails,  proxies  may be  solicited  by
personal  interview,  telephone  and telegram by  directors,  officers and other
employees  of the  Company  who  will not be  specially  compensated  for  these
services. The Company will also request that brokers,  nominees,  custodians and
other  fiduciaries  forward  soliciting  materials to the  beneficial  owners of
shares  held  of  record  by  such  brokers,  nominees,   custodians  and  other
fiduciaries.

      Certain  information  contained  in this Proxy  Statement  relating to the
occupations  and security  holdings of directors  and officers of the Company is
based upon information received from the individual directors and officers.

CYPOST CORPORATION WILL FURNISH, WITHOUT CHARGE, THOSE PORTIONS OF ITS REPORT ON
FORM 10-KSB FOR THE YEAR ENDED  DECEMBER 31, 2000, AND REPORT ON FORM 10-QSB FOR
THE FISCAL  QUARTER ENDED  SEPTEMBER  30, 2001,  NOT SUPPLIED  HEREWITH,  TO ANY
STOCKHOLDER OF RECORD ON DECEMBER 31, 2001 AND TO EACH BENEFICIAL STOCKHOLDER ON
THAT DATE UPON  WRITTEN  REQUEST  MADE TO THE  SECRETARY  OF THE COMPANY BY SUCH
STOCKHOLDER. A REASONABLE FEE FOR PHOTOCOPYING CHARGES


                                       15


WILL BE IMPOSED ON ANY MATERIALS SO REQUESTED. THESE MATERIALS ARE ALSO PUBLICLY
AVAILABLE FOR  INSPECTION  (AND DOWNLOAD) FROM THE OFFICIAL WEB SITE OF THE U.S.
SECURITIES AND EXCHANGE  COMMISSION FOUND AT WWW.SEC.GOV.  PARTIES INTERESTED IN
INSPECTING THESE MATERIALS SHOULD CLICK AND SEARCH IN THE "EDGAR" DATABASE UNDER
"CYPOST".

      PLEASE DATE,  SIGN AND RETURN THE PROXY CARD AT YOUR EARLIEST  CONVENIENCE
IN THE  ENCLOSED  RETURN  ENVELOPE.  A PROMPT  RETURN OF YOUR PROXY CARD WILL BE
APPRECIATED AS IT WILL SAVE THE EXPENSE OF FURTHER MAILINGS.

                                    By Order of the Board of Directors

                                    /s/ Sandra Lynn Warren
                                    Sandra Lynn Warren
                                    President, Secretary, Treasurer and Director


                                       16


CY POST CORPORATION
PROXY FOR ANNUAL MEETING OF STOCKHOLDERS
JANUARY 29, 2002

The undersigned hereby appoints Sandra Lynn Warren,  with power of substitution,
as proxy to represent the  undersigned at the Annual Meeting of  stockholders of
CyPost  Corporation  to be held on the 29th day of  January,  2002 at 2:00 p.m.,
local time at the  offices  of Kaplan  Gottbetter  &  Levenson,  LLP,  630 Third
Avenue,  New York,  New York  10017 and at any  adjournments  thereof,  upon the
matters set forth below and described in the notice and proxy statement for said
meeting,  copies of which have been  received  by the  undersigned;  and, in her
discretion,  upon all other matters  which may come before the meeting.  Without
otherwise  limiting the general  authorization  hereby  given,  said attorney is
instructed to vote, as follows,  the number of shares the  undersigned  would be
entitled to vote if personally present, on the matters set forth below.

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS.  THIS PROXY WILL BE
VOTED AS DIRECTED. IN THE ABSENCE OF DIRECTION, THIS PROXY WILL BE VOTED FOR THE
THREE  NOMINEES  FOR  ELECTION  AS  DIRECTORS,   FOR  THE  RATIFICATION  OF  THE
APPOINTMENT  OF GOOD  SWARTZ  BROWN & BERNS LLP,  FOR THE  PROPOSAL TO AMEND THE
COMPANY's  CERTIFICATE  OF  INCORPORATION  TO INCREASE THE COMPANY's  AUTHORIZED
CAPITALIZATION;   FOR  THE  PROPOSAL  TO  AMEND  THE  COMPANY's  CERTIFICATE  OF
INCORPORATION  TO GRANT THE BOARD AUTHORITY TO ADOPT  SHAREHOLDER  RIGHTS PLANS,
RIGHTS  AGREEMENTS OR OTHER FORMS OF POISON PILLS; AND FOR THE PROPOSAL TO AMEND
THE COMPANY's BY-LAWS.

(1)   To elect three (3)  Directors  to serve  until the next Annual  Meeting of
      Stockholders  and until their  respective  successors shall have been duly
      elected and qualified. The three nominees are:

      Sandra Lynn Warren             James T. Johnston             Javan Khazali

INSTRUCTIONB TO WITHHOLD AUTHORITY TO VOTE FOR ANY  INDIVIDUAL NOMINEE, STRIKE A
LINE THROUGH THE NOMINEE'S NAME IN THE LIST ABOVE.

(2)   To approve a proposal to amend the Company's  Certificate of Incorporation
      to increase the number of  authorized  common  shares from  30,000,000  to
      200,000,000.

               / / FOR          / / AGAINST          / / ABSTAIN

(3)   To approve a proposal to amend the Company's  Certificate of Incorporation
      to grant the board of  directors  authority  to adopt  shareholder  rights
      plans, rights agreements or other forms of poison pills.

               / / FOR          / / AGAINST          / / ABSTAIN



(4)   To approve the  engagement of the  accounting  firm of Good Swartz Brown &
      Berns LLP, as independent public accountants of the Company for the fiscal
      year ended December 31, 2001.

               / / FOR          / / AGAINST          / / ABSTAIN

(5)   To approve a proposal to amend the Company's By-Laws.

               / / FOR          / / AGAINST          / / ABSTAIN

(6)   In her discretion, upon such other matters as may properly come before the
      meeting.

               / / AUTHORIZED          / / NOT AUTHORIZED

The  shares  represented  by this  proxy  will be voted in  accordance  with the
specifications made by the undersigned herein.

Please mark,  sign, date and return this proxy in the enclosed  envelope as soon
as  possible,  even  though  you  plan to  attend  this  meeting.  To  help  our
preparations for the meeting, please check here if you plan to attend: |_|

Please  sign  exactly as your name or names  appear on your  CyPost  Corporation
stock certificate. If the shares are issued in the names of two or more persons,
all such persons should sign the proxy. A proxy executed by a corporation should
be signed in its name by its  authorized  officers.  Executors,  administrators,
trustees, and partners should indicate their positions when signing.

                               __________________________ Date: __________, 2002

                               __________________________ Date: __________, 2002

                               __________________________ Date: __________, 2002

If your address has changed, please note new address below.

Address:

______________________________

______________________________

______________________________